Topical Serum Containing Hydroxypinacolone Retinoate and Peptides in Comparison to a Laser Treatment Targeting Facial Aging

Roden Errant presented data on a new cosmeceutical serum containing Hydroxypinacolone Retinoate (HPR) and peptides for treating facial aging, suggesting it provides comparable efficacy to a single CO2 laser treatment. This topical serum is suitable for all skin types and can be used twice daily, making it accessible for patients who may not afford or prefer invasive procedures. HPR is noted for its retinoic activity, reducing irritation compared to traditional retinoids, and it enhances collagen production effectively. The clinical trial compared the serum’s effects over 16 weeks with a CO2 laser on women with facial photo damage, showing that wrinkle improvements were similar, if not slightly superior, with the serum across various wrinkle types and skin textures. The serum was effective for all Fitzpatrick skin types and proved beneficial in supporting the skin's extracellular matrix and visible signs of aging. Its formulation also prioritizes skin comfort, being gentle enough for sensitive skin and free from fragrances or allergens. Overall, the findings support the serum as an effective alternative or adjunct to laser treatments for skin aging.